Europe Companion Animal Healthcare Market

Europe Companion Animal Healthcare Market Size (2024 to 2029)

The size of the European companion animal healthcare market is expected to be worth USD 4.21 Billion in 2024 and USD 5.7 Billion by 2029, growing at a CAGR of 6.25% during the forecast period.

Companies are focusing their efforts on developing new medications and vaccines for intriguing and newly diagnosed diseases, which is expected to encourage market growth.

Key market players in the region are implementing market strategies such as mergers and acquisitions in the companion animal healthcare business to gain expertise in producing new active pharmaceutical ingredients/drugs. The prevalence of zoonotic and food-borne illnesses will be a potential concern for pet animal health, resulting in increased pet/companion ownership, which will drive the European Companion Animal Healthcare Market. Pet owners' health concerns are rising, as is their demand for better nutrition. The increasing prevalence of animal healthcare and the provision of high-quality food products have boosted the market's growth rate. Furthermore, the expansion of veterinary hospitals in both private and public entities is also boosting the market. Moreover, a rise in disposable income and current trends have increased the number of companion animals and expanded pet insurance alternatives in several regions, increasing the companion animal healthcare market demand.

Companion animal diseases are more undoubtedly to be spread to humans.

For example, dog and cat bites cause a variety of illnesses in humans. Other conditions found in pets include neoplasia, distemper, parvovirus, leukemia, panleukopenia, and viral rhinotracheitis. Many of these diseases are lethal even with adequate treatment, so most pet owners have their animals vaccinated regularly. The growing need for prophylactic vaccines will propel the market forward. Restrictions by regulatory bodies have a negative influence on antibiotics sales, growing costs, and tightening laws on animal testing have prevented several healthcare businesses from manufacturing new advanced pharmaceuticals, among the obstacles that will hinder market expansion.

This research report on the Europe Companion Animal Healthcare Market has been segmented and sub-segmented into the following categories

Europe Companion Animal Healthcare Market - By Product Type

• Feed Additives
• Pharmaceuticals
• Vaccines

Europe Companion Animal Healthcare Market - By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the companion animal healthcare market in Europe is the world's second-largest due to a rise in pet ownership government tax reduction. In addition, the market is expected to grow due to the increased implementation of regulatory standards by European regional and local governments during the overall improvement of animal healthcare. As a result, significant countries such as the United Kingdom, Germany, France, Italy, and Spain significantly contribute to the European companion animal healthcare market. Next, a biological therapeutics company producing monoclonal antibody therapy for companion animals in pain and other therapeutic areas was acquired by Zoetis in April 2017.

The UK companion animal healthcare market captured the most significant share of the companion animal healthcare market.

A high level of knowledge about the health and overall well-being of livestock and domestic animals is the primary cause for the growth of the U.K. companion animal healthcare market. In addition, the recent events have demonstrated the United Kingdom's commitment to providing the finest possible care for animals. The United Kingdom government has invested in animal health, mainly pigs and cattle, focusing on endemic disease control and treatment. The National Office for Animal Health (NOAH) released new plans in December 2020 that urge farmers to take better care of their cattle.

KEY MARKET PLAYERS

Key players operating in the Europe Companion Animal Healthcare Market profiled in this report are Bayer HealthCare Pharmaceuticals LLC, Boehringer Ingelheim, Elanco, Merck & Co., Merial, Virbac, Zoetis